Statistics
Publications
1
Citations
29
H-Index
1
Active since
2022
Affiliations
Eli Lilly (United States)(Current)
Mark R. Berglund is an author at Eli Lilly (United States) specializing in solid-phase peptide synthesis, prodrug design, and peptide bond chemistry.
Publications per year
2022–2022
1
1
1–1 of 1